Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00293696
Status:
COMPLETED
Last Update Posted:
2007-05-08
First Post:
2006-02-16
Brief Title:
CasodexZoladex Biomarkers in Localised Prostate Cancer
Sponsor:
Tampere University
Organization:
Tampere University
Study Overview
Official Title:
A Randomised Pilot Study to Evaluate the Effects of Casodex 150 mg and Zoladex 36 mg on Pathological and Genomic Tumour Markers in Subjects Undergoing Radical Prostatectomy for Localised Prostate Carcinoma
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate anti-androgen bicalutamide induced biological and molecular changes in prostate comparison to chemical castration induced goserelin ones
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None